Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Blood test reveals more gene mutations in cancer than traditional tumor biopsy

A new blood test revealed more of the gene mutations that sustain certain digestive-tract tumors than did a DNA analysis of a traditional tumor biopsy, Dana-Farber Cancer Institute investigators will report at a special symposium of the American Association for Cancer Research annual meeting in Washington, April 6-10.

8 Apr 2013

FUJIFILM showcases Aspire product line at Society of Breast Imaging conference

Building upon its legacy of technological innovations and innovation awards, FUJIFILM Medical Systems U.S.A., Inc. - the pioneer in digital mammography - will showcase its Aspire product line at the Society of Breast Imaging conference in Los Angeles, CA from April 6-9, 2013.

8 Apr 2013

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Just like a massive iceberg jutting out of the ocean, many of cancer's genetic underpinnings remain hidden under the surface, impossible to predict or map from above.

6 Apr 2013

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism, Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.

4 Apr 2013

Researchers diagnose genetic disease in embryonic DNA without biopsy

Preimplantation genetic diagnosis (PGD) technologies allow identification of genetic disorders in human preimplantation embryos after in vitro fertilization (IVF) and before the embryo is transferred back to the patient.

3 Apr 2013

Handheld ultrasound devices: an interview with Warren Ortmann, Signostics

Ultrasound devices use sound waves to image the organs of the body safely, without the use of radiation. The sound waves are produced by applying a current to a piezoelectric crystal housed in a transducer. The crystal alters shape and creates a sound wave.

3 Apr 2013

Engineers develop prototype telerobotic platform for bladder cancer treatment

Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years.

3 Apr 2013

NanoVelcro chip device can help identify cancerous cells for treating prostate cancer

A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.

2 Apr 2013

Woodside Capital to assist in growth of Spectros' flagship product

Spectros announced today the retention of Woodside Capital Partners International to explore strategic options to accelerate the growth of its proprietary second-generation perfusion monitoring platform.

1 Apr 2013

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

Prostate cancer is the most common cancer in men. Despite many advances in diagnosis and treatment over the past two decades, it remains the second most common cause of cancer related death in men.

28 Mar 2013

KineMed renews research collaboration with Pfizer for advancement of novel diabetes pathways

KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.

From Pfizer, Inc. 28 Mar 2013

Study raises alarm over loss of individual 'genomic liberty' due to gene patents

Humans don't "own" their own genes, the cellular chemicsals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire human genome for profit, report two researchers who analyzed the patents on human DNA. Their study, published March 25 in the journal Genome Medicine, raises an alarm about the loss of individual "genomic liberty."

27 Mar 2013

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Trovagene, Inc., today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus test.

27 Mar 2013

Two studies shed light on molecular biology of three blood disorders

Two studies led by investigators at Weill Cornell Medical College shed light on the molecular biology of three blood disorders, leading to novel strategies to treat these diseases.

26 Mar 2013

First multi-gene DNA sequencing test launched for cancer patients

The first multi-gene DNA sequencing test that can help predict cancer patients' responses to treatment has been launched in the National Health Service, thanks to a partnership between scientists at the University of Oxford and Oxford University Hospitals NHS Trust.

26 Mar 2013

Researchers expand hematopoietic stem cells for bone marrow transplantation

More than 50,000 stem cell transplants are performed each year worldwide. A research team led by Weill Cornell Medical College investigators may have solved a major issue of expanding adult hematopoietic stem cells (HSCs) outside the human body for clinical use in bone marrow transplantation -- a critical step towards producing a large supply of blood stem cells needed to restore a healthy blood system.

25 Mar 2013

Weill Cornell researcher suggests ways to improve patient safety, high-level care

In its 2001 report Crossing the Quality Chasm, the Institute of Medicine outlined six domains of quality in medical care: safety, effectiveness, patient-centeredness, timeliness, efficiency and equity.

24 Mar 2013

Blocked bile ducts can be effectively treated with metal stents

A multi-center analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix a painful and potentially life-threatening benign biliary stricture -- a severely blocked or narrowed bile duct.

21 Mar 2013

Weill Cornell Medical College researchers call for clearer definition of population health

Accountable Care Organizations, a key feature of the Affordable Care Act, aim to control health care costs, enhance quality in health care and improve population health. But what does "improving population health" really mean? This is the question asked in a new viewpoint article by Weill Cornell Medical College researchers published in the March 20 issue of the Journal of the American Medical Association.

20 Mar 2013

Study evaluates genetic predisposition in BPH patients developing prostate cancer

Patients with benign prostatic hyperplasia carrying prostate cancer a risk alleles are a potential target population for PCa screening and follow-up, according to a study, which was presented yesterday at the 28th Annual EAU Congress in Milan.

19 Mar 2013

Biopsy News and Research

Further Reading

Blood test reveals more gene mutations in cancer than traditional tumor biopsy

FUJIFILM showcases Aspire product line at Society of Breast Imaging conference

Individualized genomic analysis allows for tailored cancer treatment, new drug research

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Researchers diagnose genetic disease in embryonic DNA without biopsy

Handheld ultrasound devices: an interview with Warren Ortmann, Signostics

Engineers develop prototype telerobotic platform for bladder cancer treatment

NanoVelcro chip device can help identify cancerous cells for treating prostate cancer

Woodside Capital to assist in growth of Spectros' flagship product

Prostate cancer prognosis tables: an interview with Dr John B. Eifler, Brady Urological Institute of Johns Hopkins

KineMed renews research collaboration with Pfizer for advancement of novel diabetes pathways

Study raises alarm over loss of individual 'genomic liberty' due to gene patents

Trovagene introduces urine-based HPV-HR DNA test for identifying high-risk HPV strains

Two studies shed light on molecular biology of three blood disorders

First multi-gene DNA sequencing test launched for cancer patients

Researchers expand hematopoietic stem cells for bone marrow transplantation

Weill Cornell researcher suggests ways to improve patient safety, high-level care

Blocked bile ducts can be effectively treated with metal stents

Weill Cornell Medical College researchers call for clearer definition of population health

Study evaluates genetic predisposition in BPH patients developing prostate cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News